title: NADPH oxidase pathway is involved in aortic contraction induced by A3 adenosine receptor in mice.
abstract: The NADPH oxidase (Nox) subunits 1, 2 (gp91 phox), and 4 are the major sources for reactive oxygen species (ROS) in vascular tissues. In conditions such as ischemia-reperfusion and hypoxia, both ROS and adenosine are released, suggesting a possible interaction. Our aim in this study was to examine the A(3) adenosine receptor (A(3)AR)-induced vascular effects and its relation to ROS and Nox1, 2, and 4 using aortic tissues from wild-type (WT) and A(3)AR knockout (A(3)KO) mice. The selective A(3)AR agonist 2-chloro-N(6)-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (Cl-IBMECA) (10(-10)-10(-5) M) induced contraction of the aorta from WT but not from A(3)KO mice, and this contraction was inhibited by the Nox inhibitor apocynin (10(-5) M) and the ROS scavengers superoxide dismutase-polyethylene glycol and catalase-polyethylene glycol (100 U/ml each). Cl-IBMECA-induced contraction was not affected by the mast cell degranulator compound 48/80 (100 μg/ml) or the stabilizer cromolyn sodium (10(-4) M). In addition, Cl-IBMECA (10(-7) M) increased intracellular ROS generation by 35 ± 14% in WT but not in A(3)KO aorta, and this increase was inhibited by apocynin (10(-5) M), diphenyleneiodonium chloride (10(-5) M), and the A(3)AR antagonist 3-propyl-6-ethyl-5-[(ethylthio)carbonyl]-2 phenyl-4-propyl-3-pyridine carboxylate (MRS1523) (10(-5) M). Furthermore, Cl-IBMECA selectively increased the protein expression of the Nox2 subunit by 150 ± 15% in WT but not in A(3)KO mice without affecting either Nox1 or 4, and this increase was inhibited by apocynin. The mRNA of Nox2 was unchanged by Cl-IBMECA in either WT or A(3)KO aortas. In conclusion, A(3)AR enhances ROS generation, possibly through activation of Nox2, with subsequent contraction of the mouse aorta.
authors: Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV 26505, USA.
authors: Mohammed S
authors: MS
authors: El-Awady
authors: Habib R
authors: HR
authors: Ansari
authors: Daniel
authors: D
authors: Fil
authors: Stephen L
authors: SL
authors: Tilley
authors: S Jamal
authors: SJ
authors: Mustafa
references: Circ Res. 2004 Oct 15;95(8):773-9
references: 15388638
references: J Biol Chem. 2008 Dec 12;283(50):34976-82
references: 18922793
references: Handb Exp Pharmacol. 2009;(193):161-88
references: 19639282
references: Biull Eksp Biol Med. 1995 Apr;119(4):361-5
references: 7620128
references: Cardiovasc Res. 2008 Nov 1;80(2):271-9
references: 18596059
references: Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5543-8
references: 18378896
references: FASEB J. 1991 Jan;5(1):98-103
references: 1703974
references: Am J Physiol Heart Circ Physiol. 2009 Sep;297(3):H1032-9
references: 19592614
references: Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3448-55
references: 17921329
references: Curr Opin Pharmacol. 2010 Apr;10(2):122-6
references: 20149739
references: J Leukoc Biol. 1999 Sep;66(3):495-501
references: 10496321
references: J Cereb Blood Flow Metab. 2010 Oct;30(10):1777-90
references: 20531463
references: J Biol Chem. 2000 Feb 11;275(6):4429-34
references: 10660615
references: Neoplasia. 2009 Nov;11(11):1132-45
references: 19881949
references: Life Sci. 2006 Apr 18;78(21):2426-37
references: 16300799
references: J Pharmacol Exp Ther. 2009 Jul;330(1):99-108
references: 19395654
references: Free Radic Biol Med. 1999 Sep;27(5-6):612-6
references: 10490282
references: Biochim Biophys Acta. 2000 Mar 17;1500(3):280-90
references: 10699369
references: Eur J Pharmacol. 1996 Jul 25;308(3):311-4
references: 8858305
references: Free Radic Biol Med. 2008 Apr 1;44(7):1433-42
references: 18206127
references: Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H719-25
references: 16920807
references: Biotechniques. 2004 Jun;36(6):1030-7
references: 15211754
references: Pharmacol Ther. 2001 Aug;91(2):133-47
references: 11728606
references: Circ Res. 2000 Jul 7;87(1):26-32
references: 10884368
references: Circ Res. 1996 Apr;78(4):627-34
references: 8635220
references: BMC Evol Biol. 2007 Jul 06;7:109
references: 17612411
references: Circ Res. 2002 Sep 6;91(5):406-13
references: 12215489
references: FEBS Lett. 2005 Apr 25;579(11):2533-40
references: 15848200
references: Gene. 2001 May 16;269(1-2):131-40
references: 11376945
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Eur J Pharmacol. 2003 Sep 23;477(3):235-45
references: 14522362
references: Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2183-9
references: 12003827
references: Am J Physiol Regul Integr Comp Physiol. 2009 Jan;296(1):R72-9
references: 18987286
references: Acta Pharmacol Sin. 2010 Apr;31(4):413-20
references: 20348945
references: J Leukoc Biol. 2006 Jul;80(1):152-63
references: 16624933
references: Chem Res Toxicol. 1992 Nov-Dec;5(6):834-42
references: 1336991